Next-Chemx Corporation. (CHMX) — SEC Filings

Q: What are the key financial highlights for Next-Chemx Corporation.?

Key financial highlights for Next-Chemx Corporation. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Next-Chemx Corporation.?

Key executives at Next-Chemx Corporation. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Next-Chemx Corporation. stock?

Risk factors for Next-Chemx Corporation. (CHMX) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Next-Chemx Corporation.?

Forward-looking statements and predictions from Next-Chemx Corporation. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Next-Chemx Corporation.. Recent 10-Q/A filing on Nov 18, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Next-Chemx Corporation. on SEC EDGAR

Overview

Next-Chemx Corporation. (CHMX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q/A filed on Nov 18, 2025: NEXT-ChemX Corporation (CHMX) filed a 10-Q/A for the quarter ended September 30, 2024, restating previous financial statements due to issues with its former auditor, BF Borgers CPA PC, and subsequent review by new auditor Fruci & Associates II PLLC. The restatement included significant adjustments:

Sentiment Summary

Across 17 filings, the sentiment breakdown is: 2 bearish, 14 neutral, 1 mixed. The dominant filing sentiment for Next-Chemx Corporation. is neutral.

Filing Type Overview

Next-Chemx Corporation. (CHMX) has filed 3 10-Q/A, 6 8-K, 5 10-Q, 2 10-K, 1 10-K/A with the SEC between Apr 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent Filings (17)

NEXT-ChemX Restates Q3, Faces Mounting Deficit Amid Auditor Fallout — 10-Q/A · Nov 18, 2025 Risk: high
NEXT-ChemX Corporation (CHMX) filed a 10-Q/A for the quarter ended September 30, 2024, restating previous financial statements due to issues with its former aud
NEXT-ChemX Corp. Files 8-K — 8-K · Nov 4, 2025 Risk: low
On October 23, 2025, NEXT-ChemX Corporation filed an 8-K report detailing other events. The company, formerly known as AllyMe Group, Inc./NV, Wewin Group Corp.,
NEXT-ChemX Restates Q2, Faces Mounting Losses Amid Auditor Fallout — 10-Q/A · Sep 16, 2025 Risk: high
NEXT-ChemX Corporation (CHMX) filed a restated 10-Q/A for the quarter ended June 30, 2024, primarily due to issues with its former auditor, BF Borgers CPA PC, a
NEXT-ChemX Corp. Files Q2 2025 10-Q — 10-Q · Aug 19, 2025 Risk: low
NEXT-ChemX Corporation filed a 10-Q for the period ending June 30, 2025. The company, formerly known as AllyMe Group, Inc./NV, is incorporated in Nevada and ope
NEXT-ChemX Narrows Loss to $1K, Boosted by Restatement & Private Placement — 10-Q/A · Jun 30, 2025 Risk: high
NEXT-ChemX Corporation (CHMX) reported no revenue for the three months ended March 31, 2024, consistent with the prior year period, indicating its pre-revenue s
NEXT-ChemX Corp. Files Q1 2025 10-Q — 10-Q · May 19, 2025 Risk: medium
NEXT-ChemX Corporation filed its 10-Q for the period ending March 31, 2025. The company, formerly known as AllyMe Group, Inc./NV, is based in Austin, TX, and op
NEXT-ChemX Corp. Files 2024 10-K — 10-K · Apr 30, 2025 Risk: low
NEXT-ChemX Corporation filed its 2024 10-K on April 30, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as AllyMe Group
NEXT-ChemX Files 2023 Annual Report Amendment — 10-K/A · Apr 28, 2025 Risk: low
NEXT-ChemX Corporation filed an amendment (10-K/A) to its annual report on April 28, 2025, for the fiscal year ending December 31, 2023. The company, previously
NEXT-ChemX Files Q3 10-Q Report — 10-Q · Nov 19, 2024 Risk: low
NEXT-ChemX Corporation filed its Q3 10-Q report on November 19, 2024, covering the period ending September 30, 2024. The company, formerly known as AllyMe Group
NEXT-ChemX Files 8-K on Equity Sales & Security Holder Rights — 8-K · Sep 27, 2024 Risk: medium
On September 23, 2024, NEXT-ChemX Corporation filed an 8-K report detailing unregistered sales of equity securities. The filing also addresses material modifica
NEXT-ChemX Corp. Files Q2 2024 10-Q — 10-Q · Aug 19, 2024 Risk: low
NEXT-ChemX Corporation filed its 10-Q for the period ending June 30, 2024. The company, formerly known as AllyMe Group, Inc./NV, is incorporated in Nevada and o
NEXT-ChemX Corp. Files Q1 2024 10-Q — 10-Q · Jul 15, 2024 Risk: low
NEXT-ChemX Corporation filed its 10-Q for the period ending March 31, 2024. The company, formerly known as AllyMe Group, Inc./NV, is incorporated in Nevada and
NEXT-ChemX Reports Material Impairment — 8-K · Jun 20, 2024 Risk: medium
NEXT-ChemX Corporation filed an 8-K on June 20, 2024, reporting a material impairment as of June 14, 2024. The filing does not specify the exact nature or amoun
NEXT-ChemX Corp. Files 8-K on Equity Sales — 8-K · Jun 10, 2024 Risk: medium
NEXT-ChemX Corporation filed an 8-K on June 10, 2024, reporting on unregistered sales of equity securities and material modifications to security holder rights,
NEXT-ChemX Corp. Changes Independent Accountant — 8-K · May 16, 2024 Risk: medium
NEXT-ChemX Corporation announced on May 15, 2024, a change in its certifying accountant. The company has dismissed its former independent registered public acco
NEXT-ChemX Changes Auditors — 8-K · May 7, 2024 Risk: medium
NEXT-ChemX Corporation announced on May 3, 2023, that it has dismissed its former independent registered public accounting firm, W.F. Associates, Inc. The compa
NEXT-ChemX Corporation Files 2023 Annual Report — 10-K · Apr 1, 2024 Risk: medium
NEXT-ChemX Corporation. (CHMX) filed a Annual Report (10-K) with the SEC on April 1, 2024. NEXT-ChemX Corporation, formerly AllyMe Group, Inc./NV, filed its 10-

Risk Profile

Risk Assessment: Of CHMX's 17 recent filings, 3 were flagged as high-risk, 7 as medium-risk, and 7 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

John Michel Johnson
Benton Wilcoxon
Zilin Wang
Kenneth Mollicone
Miss Anne Mollicone
Mr Arastou Mahjoory

Industry Context

The chemical industry is characterized by intense competition, significant R&D investment, and stringent regulatory oversight. Companies often focus on specialized niches, innovation in materials science, and sustainable practices to gain a competitive edge. NEXT-ChemX appears to be operating in a segment requiring technological innovation, as evidenced by its focus on intangible assets like technology and patents.

Top Tags

10-Q (5) · Restatement (3) · financials (3) · Auditor Issues (2) · Going Concern (2) · Intangible Assets (2) · Lithium Extraction (2) · quarterly-report (2) · Chemical Products (2) · 10-K (2)

Key Numbers

Adjustment to intangible asset value: $570,484 — Due to reevaluation of technology's useful life as of September 30, 2024
Amortization charge against intangible asset: $262,119 — Resulting from the reevaluation of technology's useful life
Readjustment to retained earnings: $308,365 — Included in the balance sheet restatement
Net loss for nine months ended September 30, 2024: $1,320,269 — Restated net loss, compared to $1,778,554 in 2023
Accumulated deficit as of September 30, 2024: $7,832,379 — Increased from $6,512,110 at December 31, 2023
Total Liabilities as of September 30, 2024: $5,690,714 — Increased from $3,932,425 at December 31, 2023
Common Stock Shares Outstanding: 28,546,834 — As of October 31, 2025 and September 30, 2024
Non-Current Notes Payable: $1,220,004 — As of September 30, 2024, up from $0 at December 31, 2023
Cash at end of period: $35,386 — As of September 30, 2024, up from $2,458 at beginning of year
Net loss for six months ended June 30, 2024: $939,787 — Increased from $855,696 in prior year period
Accumulated deficit as of June 30, 2024: $7,451,897 — Indicates significant historical losses
Net cash used in operating activities for six months ended June 30, 2024: $861,765 — Substantially increased from $169,669 in prior year period
Retained earnings adjustment: $308,365 — Included in balance sheet readjustment
Estimated capital needed: $3 million — To manage ongoing technology development and market effectively
Common shares outstanding: 28,546,834 — As of June 30, 2024 and September 16, 2025

Frequently Asked Questions

What are the latest SEC filings for Next-Chemx Corporation. (CHMX)?

Next-Chemx Corporation. has 17 recent SEC filings from Apr 2024 to Nov 2025, including 6 8-K, 5 10-Q, 3 10-Q/A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of CHMX filings?

Across 17 filings, the sentiment breakdown is: 2 bearish, 14 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Next-Chemx Corporation. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Next-Chemx Corporation. (CHMX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Next-Chemx Corporation.?

Key financial highlights from Next-Chemx Corporation.'s most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for CHMX?

The investment thesis for CHMX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Next-Chemx Corporation.?

Key executives identified across Next-Chemx Corporation.'s filings include John Michel Johnson, Benton Wilcoxon, Zilin Wang, Kenneth Mollicone, Miss Anne Mollicone and 1 others.

What are the main risk factors for Next-Chemx Corporation. stock?

Of CHMX's 17 assessed filings, 3 were flagged high-risk, 7 medium-risk, and 7 low-risk.

What are recent predictions and forward guidance from Next-Chemx Corporation.?

Forward guidance and predictions for Next-Chemx Corporation. are extracted from SEC filings as they are enriched.